Total Payments
$3,705
2023 Payments
$23.39
Companies
5
Transactions
11
Medicare Patients
1,861
Medicare Billing
$219,320
Payment Breakdown by Category
Research$3,622 (97.8%)
Food & Beverage$83.06 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3,622 | 7 | 97.8% |
| Food and Beverage | $83.06 | 4 | 2.2% |
Payments by Type
Research
$3,622
7 transactions
General
$83.06
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim b.v. | $3,622 | 7 | $0 (2018) |
| Dynavax Technologies Corporation | $26.44 | 1 | $0 (2018) |
| Novo Nordisk Inc | $23.39 | 1 | $0 (2023) |
| Valneva USA, Inc. | $21.76 | 1 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $11.47 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $23.39 | 1 | Novo Nordisk Inc ($23.39) |
| 2019 | $11.47 | 1 | Merck Sharp & Dohme Corporation ($11.47) |
| 2018 | $3,670 | 9 | Boehringer Ingelheim b.v. ($3,622) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/16/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Diabetes | ||||||
| 03/27/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: WOMENS HEALTH | ||||||
| 08/15/2018 | Valneva USA, Inc. | IXIARO (Biological) | Food and Beverage | Cash or cash equivalent | $21.76 | General |
| 07/12/2018 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Hepatitis B Vaccine | ||||||
| 01/17/2018 | Boehringer Ingelheim b.v. | TRADJENTA (Drug) | — | Cash or cash equivalent | $1,144.00 | Research |
| Study: CARMELINA • Category: DIABETES | ||||||
| 01/17/2018 | Boehringer Ingelheim b.v. | TRADJENTA (Drug) | — | Cash or cash equivalent | $1,106.00 | Research |
| Study: CARMELINA • Category: DIABETES | ||||||
| 01/17/2018 | Boehringer Ingelheim b.v. | TRADJENTA (Drug) | — | Cash or cash equivalent | $1,106.00 | Research |
| Study: CARMELINA • Category: DIABETES | ||||||
| 01/17/2018 | Boehringer Ingelheim b.v. | TRADJENTA (Drug) | — | Cash or cash equivalent | $87.00 | Research |
| Study: CARMELINA • Category: DIABETES | ||||||
| 01/17/2018 | Boehringer Ingelheim b.v. | TRADJENTA (Drug) | — | Cash or cash equivalent | $87.00 | Research |
| Study: CARMELINA • Category: DIABETES | ||||||
| 01/17/2018 | Boehringer Ingelheim b.v. | TRADJENTA (Drug) | — | Cash or cash equivalent | $46.00 | Research |
| Study: CARMELINA • Category: DIABETES | ||||||
| 01/17/2018 | Boehringer Ingelheim b.v. | TRADJENTA (Drug) | — | Cash or cash equivalent | $46.00 | Research |
| Study: CARMELINA • Category: DIABETES | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CARMELINA | Boehringer Ingelheim b.v. | $3,622 | 7 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 664 | 1,065 | $200,538 | $80,859 |
| 2022 | 13 | 595 | 967 | $176,791 | $69,479 |
| 2021 | 9 | 602 | 782 | $184,408 | $68,983 |
Total Patients
1,861
Total Services
2,814
Medicare Billing
$219,320
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 143 | 275 | $52,344 | $21,485 | 41.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 135 | 353 | $49,678 | $18,770 | 37.8% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 112 | 119 | $31,033 | $12,285 | 39.6% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 59 | 88 | $23,774 | $10,241 | 43.1% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 59 | 61 | $20,157 | $8,482 | 42.1% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2023 | 64 | 68 | $10,244 | $4,227 | 41.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 39 | 41 | $5,822 | $2,674 | 45.9% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 36 | 38 | $5,396 | $2,250 | 41.7% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 17 | 22 | $2,090 | $444.53 | 21.3% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 80 | 174 | $47,008 | $18,172 | 38.7% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 73 | 147 | $20,687 | $7,941 | 38.4% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 55 | 101 | $19,224 | $7,201 | 37.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 57 | 59 | $16,225 | $6,653 | 41.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 71 | 103 | $14,935 | $6,172 | 41.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 31 | 70 | $14,700 | $6,001 | 40.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 81 | 157 | $12,560 | $5,089 | 40.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 22 | $8,910 | $3,654 | 41.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 39 | 39 | $8,190 | $3,156 | 38.5% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 24 | 24 | $6,259 | $2,410 | 38.5% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 38 | 46 | $4,335 | $1,566 | 36.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 13 | 13 | $1,950 | $786.52 | 40.3% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2022 | 12 | 12 | $1,808 | $676.20 | 37.4% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 158 | 257 | $51,400 | $18,651 | 36.3% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 118 | 161 | $47,173 | $17,637 | 37.4% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 135 | 140 | $39,340 | $14,718 | 37.4% |
About Dr. Joshua Kretchmar, DO
Dr. Joshua Kretchmar, DO is a Family Medicine healthcare provider based in Kent, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2014. The National Provider Identifier (NPI) number assigned to this provider is 1629485701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Kretchmar, DO has received a total of $3,705 in payments from pharmaceutical and medical device companies, with $23.39 received in 2023. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "" ($3,622).
As a Medicare-enrolled provider, Kretchmar has provided services to 1,861 Medicare beneficiaries, totaling 2,814 services with total Medicare billing of $219,320. Data is available for 3 years (2021–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Kent, WA
- Active Since 07/21/2014
- Last Updated 11/25/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1629485701
Products in Payments
- TRADJENTA (Drug) $3,622
- Heplisav-B (Drug) $26.44
- Rybelsus (Drug) $23.39
- IXIARO (Biological) $21.76
- NEXPLANON (Drug) $11.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kent
Robert Larson, M.d, M.D
Family Medicine — Payments: $10,926
Family Medicine $10,926
Dr. Virginia Factor, D.o, D.O
Family Medicine — Payments: $9,097
Family Medicine $9,097
Raymond Leone, D.o, D.O
Family Medicine — Payments: $4,892
Family Medicine $4,892
Miss. Charanjit Lamba, Md, MD
Family Medicine — Payments: $2,108
Family Medicine $2,108
Dr. Lisa Kennedy, M.d, M.D
Family Medicine — Payments: $1,363
Family Medicine $1,363
Joseph Chase, Md, MD
Family Medicine — Payments: $1,302
Family Medicine $1,302